113 related articles for article (PubMed ID: 2830954)
1. Reduced production of tumor necrosis factor by mononuclear cells in hairy cell leukemia patients and improvement following interferon therapy.
Aderka D; Levo Y; Ramot B; Michalevicz R; Meytes D; Shaklai M; Hahn T; Holtmann H; Revel M; Wallach D
Cancer; 1987 Nov; 60(9):2208-12. PubMed ID: 2830954
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor induction by Sendai virus.
Aderka D; Holtmann H; Toker L; Hahn T; Wallach D
J Immunol; 1986 Apr; 136(8):2938-42. PubMed ID: 3007608
[TBL] [Abstract][Full Text] [Related]
3. Deficient IFN alpha production in hairy cell leukemia.
Porzsolt F; Janik R; Heil G; Brudler O; Raghavachar A; Scholz S; Papendick U; Heimpel H
Blut; 1986 Mar; 52(3):185-90. PubMed ID: 3006840
[TBL] [Abstract][Full Text] [Related]
4. Constitutive production of tumor necrosis factor-alpha in hairy cell leukemia: possible role in the pathogenesis of the cytopenia(s) and effect of treatment with interferon-alpha.
Foa R; Guarini A; Francia di Celle P; Trentin L; Gillio Tos A; Bellone G; Carbone A; Attisano C; Massaia M; Raspadori D
J Clin Oncol; 1992 Jun; 10(6):954-9. PubMed ID: 1588375
[TBL] [Abstract][Full Text] [Related]
5. Hairy cell leukemia: an interferon deficient disease?
Hofmann V; Fehr J; Sauter C; Ottino J
Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
[TBL] [Abstract][Full Text] [Related]
6. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
[TBL] [Abstract][Full Text] [Related]
7. Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation.
Baran J; Kowalczyk D; Ozóg M; Zembala M
Clin Diagn Lab Immunol; 2001 Mar; 8(2):303-13. PubMed ID: 11238213
[TBL] [Abstract][Full Text] [Related]
8. Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease.
Foa R; Massaia M; Cardona S; Tos AG; Bianchi A; Attisano C; Guarini A; di Celle PF; Fierro MT
Blood; 1990 Jul; 76(2):393-400. PubMed ID: 2114936
[TBL] [Abstract][Full Text] [Related]
9. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy.
Ehmann WC; Silber R
Am J Med; 1986 Jun; 80(6):1111-4. PubMed ID: 3728508
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatment.
Flandrin G; Sigaux F; Castaigne S; Billard C; Aguet M; Boiron M; Falcoff E; Degos L
Blood; 1986 Mar; 67(3):817-20. PubMed ID: 3947748
[TBL] [Abstract][Full Text] [Related]
11. Generation of procoagulant activity by hairy cells in response to endotoxin and phorbol esters.
Viero P; Cortelazzo S; Barbui T; Semeraro N
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):857-62. PubMed ID: 3770042
[TBL] [Abstract][Full Text] [Related]
12. Inadequate production of hematopoietic growth factors in hairy cell leukemia: up-regulation of interleukin 6 by recombinant IFN-alpha in vitro.
Schwarzmeier JD; Hilgarth M; Nguyen ST; Shehata M; Gruber G; Spittler A; Willheim M; Boltz-Nitulescu G; Höcker P; Berger R
Cancer Res; 1996 Oct; 56(20):4679-85. PubMed ID: 8840984
[TBL] [Abstract][Full Text] [Related]
13. Type I interferons (IFN-alpha and -beta) suppress cytotoxin (tumor necrosis factor-alpha and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cell.
Abu-Khabar KS; Armstrong JA; Ho M
J Leukoc Biol; 1992 Aug; 52(2):165-72. PubMed ID: 1506772
[TBL] [Abstract][Full Text] [Related]
14. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
[TBL] [Abstract][Full Text] [Related]
15. Relationship of the clinical response and binding of recombinant interferon alpha in patients with lymphoproliferative diseases.
Faltynek CR; Princler GL; Rossio JL; Ruscetti FW; Maluish AE; Abrams PG; Foon KA
Blood; 1986 Apr; 67(4):1077-82. PubMed ID: 2937469
[TBL] [Abstract][Full Text] [Related]
16. The role of interferon in the treatment of hairy cell leukemia.
Ratain MJ; Vardiman JW; Golomb HM
Semin Oncol; 1986 Sep; 13(3 Suppl 2):21-8. PubMed ID: 3532332
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
Shehata M; Schwarzmeier JD; Nguyen ST; Hilgarth M; Berger R; Hubmann R; Kickmaier S; Decker T
Cancer Res; 2000 Oct; 60(19):5420-6. PubMed ID: 11034083
[TBL] [Abstract][Full Text] [Related]
18. Recombinant beta-serine-interferon in hairy cell leukemia compared prospectively with results with recombinant alpha-interferon.
Glaspy JA; Marcus SG; Ambersley J; Golde DW
Cancer; 1989 Jul; 64(2):409-13. PubMed ID: 2736487
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow changes in patients with hairy cell leukemia treated by recombinant alpha 2-interferon.
Naeim F; Jacobs AD
Hum Pathol; 1985 Dec; 16(12):1200-5. PubMed ID: 4065882
[TBL] [Abstract][Full Text] [Related]
20. Interferon alpha in the treatment of hairy cell leukemia.
Castaigne S; Sigaux F; Cantell K; Falcoff E; Boiron M; Flandrin G; Degos L
Cancer; 1986 Apr; 57(8 Suppl):1681-4. PubMed ID: 3948138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
